Bolt Biotherapeutics, Inc. (BOLT)

NASDAQ: BOLT · Real-Time Price · USD

3.665

+0.465 (14.53%)

At close: Aug 21, 2026, 4:00 PM EDT

3.660

-0.005 (-0.14%)

After-hours: Aug 21, 2026, 7:14 PM EDT

Bolt Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	12.86	11.7	7.21	10.81	9.24	27.38
Short-Term Investments	4.74	15.8	40.12	91.38	159.64	158.84
Cash & Short-Term Investments	17.6	27.51	47.32	102.19	168.89	186.22
Cash Growth	-49.39%	-41.88%	-53.69%	-39.49%	-9.31%	715.39%
Other Receivables	0.01	0.97	1.17	0.6	-	-
Receivables	0.01	0.97	1.17	0.6	-	-
Prepaid Expenses	2.75	1.41	1.49	2.74	3.86	2.94
Restricted Cash	0.2	0.2	0.78	-	-	-
Other Current Assets	-	0.18	0.06	0.18	-	-
Total Current Assets	20.56	30.26	50.81	105.71	172.75	189.16
Property, Plant & Equipment	17.65	20.48	24.9	24.08	28.53	30.6
Long-Term Investments	0.51	4.34	22.88	26.41	23.94	85.35
Long-Term Deferred Charges	-	0.14	0.05	0.37	-	-
Other Long-Term Assets	1.63	1.54	0.99	3.22	2.59	2.61
Total Assets	40.34	56.75	99.63	159.78	227.81	307.72

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.87	1.44	1.51	2.99	3.59	3.57
Accrued Expenses	3.06	2.97	8.34	12.49	15.14	12.38
Current Portion of Leases	3.09	2.83	2.25	2.78	2.39	2.5
Current Unearned Revenue	0.82	0.45	3.02	2.2	1.99	2.87
Other Current Liabilities	0.03	0.74	0.74	-	-	-
Total Current Liabilities	7.87	8.44	15.86	20.46	23.12	21.33
Long-Term Leases	18.53	20.13	22.96	17.44	20.22	21.85
Long-Term Unearned Revenue	1.17	1.54	3.62	9.11	12.92	14.21
Other Long-Term Liabilities	0.13	0.13	-	0.04	0.04	0.21
Total Liabilities	27.7	30.24	42.43	47.04	56.3	57.6

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Additional Paid-In Capital	488.43	487.31	484.5	476.99	467.51	457.43
Retained Earnings	-475.74	-460.78	-427.4	-364.29	-295.09	-206.99
Comprehensive Income & Other	-0.04	-0.02	0.1	0.04	-0.92	-0.32
Total Common Equity	12.64	26.51	57.2	112.74	171.51	250.12
Shareholders' Equity	12.64	26.51	57.2	112.74	171.51	250.12
Total Liabilities & Equity	40.34	56.75	99.63	159.78	227.81	307.72

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	21.62	22.96	25.21	20.22	22.61	24.36
Net Cash (Debt)	-4.03	4.55	22.11	81.97	146.28	161.86
Net Cash Growth	-	-79.44%	-73.02%	-43.96%	-9.63%	1253.27%
Net Cash Per Share	-2.30	2.43	11.58	43.36	78.31	97.52
Filing Date Shares Outstanding	1.93	1.92	1.92	1.91	1.89	1.87
Total Common Shares Outstanding	1.93	1.92	1.92	1.91	1.89	1.87
Working Capital	12.7	21.83	34.96	85.25	149.63	167.83
Book Value Per Share	6.56	13.80	29.84	59.16	90.75	133.75
Tangible Book Value	12.64	26.51	57.2	112.74	171.51	250.12
Tangible Book Value Per Share	6.56	13.80	29.84	59.16	90.75	133.75
Machinery	3.83	8.27	10.13	10.42	10.1	8.26
Leasehold Improvements	0.36	0.36	0.29	0.29	0.27	0.15

SEC Filings: 10-K · 10-Q